Efficacy of the Novel Cryoballoon Introduction The cryoballoon technology has the potential
to isolate a pulmonary vein (PV) with a single energy application. However, using the first …

Background The second-generation cryoballoon (CB2) provides effective and durable
pulmonary vein isolation (PVI) associated with encouraging clinical outcome data. The novel …

Ablation Time and Active Cryoballoon Deflation Introduction Optimal cryoballoon ablation
parameters for pulmonary vein (PV) isolation remain to be defined. We conducted a …

Introduction Recently a novel cryoballoon system (POLARx, Boston Scientific) became
available for the treatment of atrial fibrillation. This cryoballoon is comparable with Arctic …

Introduction: Cryoballoon (CB) ablation represents a novel technology for pulmonary vein
isolation (PVI). We investigated feasibility and safety of CBPVI, utilizing a novel spiral …

Coulombe—Improved Performance of SecondGeneration Cryoballoon Introduction A novel
cryoballoon with improved refrigerant distribution promises better pulmonary vein (PV) …

Aims Cryoballoon (CB)-based pulmonary vein isolation (PVI) is an established treatment for
symptomatic atrial fibrillation (AF). In the present study, we sought to assess the efficacy and …

Background Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI)
has demonstrated encouraging clinical results in the treatment of paroxysmal (PAF) and …

Background—The second-generation cryoballoon is effective in achieving acute pulmonary
vein isolation (PVI) and favorable clinical outcome. To date, no data are available on factors …

Background Cryoballoon technique is an innovative alternative to radiofrequency ablation
for atrial fibrillation (AF). However, with current cryoballoon application techniques, the …